NM_002439.5:c.1A>T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PVS1_ModerateBS2
The NM_002439.5(MSH3):c.1A>T(p.Met1?) variant causes a initiator codon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000163 in 1,597,606 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002439.5 initiator_codon
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH3 | ENST00000265081.7 | c.1A>T | p.Met1? | initiator_codon_variant | Exon 1 of 24 | 1 | NM_002439.5 | ENSP00000265081.6 | ||
MSH3 | ENST00000667069.1 | c.1A>T | p.Met1? | initiator_codon_variant | Exon 1 of 22 | ENSP00000499502.1 | ||||
DHFR | ENST00000439211.7 | c.-239T>A | 5_prime_UTR_variant | Exon 1 of 6 | 1 | NM_000791.4 | ENSP00000396308.2 | |||
MSH3 | ENST00000670357.1 | n.1A>T | non_coding_transcript_exon_variant | Exon 1 of 25 | ENSP00000499791.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151566Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000436 AC: 1AN: 229348Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 126172
GnomAD4 exome AF: 0.0000166 AC: 24AN: 1446040Hom.: 0 Cov.: 35 AF XY: 0.0000139 AC XY: 10AN XY: 719748
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151566Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73986
ClinVar
Submissions by phenotype
not provided Uncertain:2
Initiation codon variant in a gene for which loss-of-function is a known mechanism of disease; however, a downstream in-frame ATG, p.Met115, could serve as an alternate initiator codon; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 33332384) -
This sequence change affects the initiator methionine of the MSH3 mRNA. The next in-frame methionine is located at codon 115. This variant is present in population databases (rs775714088, gnomAD 0.001%). This variant has not been reported in the literature in individuals affected with MSH3-related conditions. ClinVar contains an entry for this variant (Variation ID: 663823). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.M1? variant (also known as c.1A>T) is located in coding exon 1 of the MSH3 gene and results from a A to T substitution at nucleotide position 1. This alters the methionine residue at the initiation codon (ATG). This variant was reported in an individual with pediatric Ewing sarcoma (Byrjalsen A et al. PLoS Genet. 2020 12;16(12):e1009231). Variations that modify the initiation codon (ATG) are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame; however, there is an in-frame methionine 114 amino acids from the initiation site, which may result in N-terminal truncation of unknown functional significance. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at